MUC13 and colorectal carcinoma: Sheng et al. evaluated 88 cases of CRC and found that low MUC13 expression (by IHC) predicted a significantly reduced 5-year survival of 45% (n = 60) compared to 90% (n = 28) for high-MUC13-expressing tumors (p-value of 0.0006) [105].